The Swedish Institute for Health Economics has analyzed data from 31 European countries – including Switzerland – over a period of almost 30 years and compiled some impressive facts. According to the study, although there are more and more newly diagnosed cases of cancer, survival rates are also increasing. The latter is mainly attributed to advances in treatment options and early detection. In addition to the status quo, future scenarios are also discussed.
Autoren
- Mirjam Peter, M.Sc.
Publikation
- HAUSARZT PRAXIS
Related Topics
You May Also Like
- AI in neurology
Control instead of a flood of data: AI makes big data and wearables usable
- Participation of the patient
Adherence in psychiatry
- Eosinophilic esophagitis
EoE rarely occurs in isolation
- Lung cancer with EGFR mutation
New perspectives in first-line therapy
- Sleep disorder
Sleep medicine in transition: new goals and a reassessment of old hypnotics
- Ginkgo biloba extract in the Alzheimer's mouse model
Effects on disease-associated microglia subpopulations
- "Patients W.A.I.T Indicator"
Access to medicines – how does Switzerland compare across Europe?
- Osteoporosis